Will it breach the 70/$ mark for now? How low could the INR go, is the big question doing the rounds in the market these days? Broadly, 4 factors will drive the rupee weaker and 70/$ may become the new normal. Here is why! Rates headed down from here… Estimates wary about how much rates…
A sharp correction in November poses some difficult questions… November was always supposed to be a tumultuous month for markets considering US elections and Fed rate outlook. However, the demonetization drive actually spooked the Nifty. Of course, FII selling also played its part in depressing prices during the month. Here is a low-down on sectors…
Going by the CMIE estimates, liquidity could hurt growth badly… The serpentine queues outside ATMs and bank branches may be gradually reducing but the squeeze is far from over. The redoubtable Dr. Manmohan Singh has already referred to a 2% loss in GDP and global FIIs are concurring. How bad could it really get? CMIE…
Finally, the good news seems to be trickling in… It may be too early to call it a game-changer. But, the sentiments around pharma stocks surely seem to be changing. It is not just about Trump or Hilary Clinton. Four factors are combining to make pharma sector look attractive from a long term investment perspective.…
What could be the long-term implications? Even as Trump was racing away, India was fighting a new battle against black money. In a swift move, the Indian government decided to do away with 500 and 1000-INR notes overnight. In the first few days, it has surely created chaos on the streets. But that may be…
Four things the world must now prepare for… It was not just a surprising win but also an emphatic one. Contrary to popular expectations, Trump has emerged as the 45th President to occupy the White House. The world needs to prepare for four key changes that may happen… Tough time for immigrants… It is not…
One more GST challenge is out of the way… With the GST Council deciding on a 4-tier structure for rates, the big challenge is finally out of the way. Although, there are still some differences on centre-state sharing, they are minor factors. The big story now is to understand the key takeaways from the GST…
They are back in the news for all the wrong reasons… Pharma companies are back in the news, albeit for all the wrong reasons. The sharp correction in pharma stocks was indicative of 3 major problems that pharma companies are facing today. US DOJ launches investigation… Over the last few years, the US has been…
A sharp uptick in Manufacturing and Service PMI… The Purchasing Managers Index (PMI) is reported by IHS Markit on a monthly basis on the first day of next month. The above chart clearly indicates an uptrend in both the services PMI and the manufacturing PMI. The level of 50 is the cut-off point for PMI.…
Why have FIIs been net sellers in debt in October? For the month of October FPIs have sold over $700 million of bonds on a net basis. There are 3 things that you need to understand at the very outset. Firstly, $700 million is not really a big number to get worried about. Secondly, FPIs…
